drug · small molecule
patient view →metyrosine
Phase 2updated 2mo agoby Yamo Pharmaceuticals LLC🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for 3 indications.
indications
indications
Parkinson's Disease
targets
Tyrosine 3-monooxygenase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that